<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04869826</url>
  </required_header>
  <id_info>
    <org_study_id>RS#: 2021-3003; R#: 101246</org_study_id>
    <secondary_id>STP-PW2-002</secondary_id>
    <nct_id>NCT04869826</nct_id>
  </id_info>
  <brief_title>Calibration of a Wrist Cuff Blood Pressure Device, According to the AAMI/ESH/ISO Universal Standard</brief_title>
  <official_title>Calibration of the Cloud DX Pulsewave Health Monitor (PAD-2A) Oscillometric Wrist Cuff Home Blood Pressure Monitor, According to the AAMI/ESH/ISO Universal Standard (ISO 81060-2: AMD_2020) (CCV-4)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Research New Brunswick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cloud DX Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dalhousie University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Horizon Health Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New Brunswick Health Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiovascular Research New Brunswick</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to calibrate the blood pressure measurements of the Pulsewave&#xD;
      Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer&#xD;
      measurements via an aneroid sphygmomanometer (reference device), as per the methodology&#xD;
      described in the ISO 81060-2: AMD_2020 protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The plan for this study is to calibrate the blood pressure measurements of the PAD-2A device&#xD;
      with the dual-observer blood pressure measurements via an aneroid sphygmomanometer (reference&#xD;
      device), as per the ISO 81060-2: AMD_2020 protocol. The data will be collected and analyzed&#xD;
      in order to calibrate the PAD-2A device blood pressure measurements to be within 5±8 mmHg of&#xD;
      the average of the dual-observer auscultatory blood pressure measurements by adjusting the&#xD;
      device algorithm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic Pressure</measure>
    <time_frame>From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds)</time_frame>
    <description>Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic Pressure</measure>
    <time_frame>From the start of manual inflation of the upper arm blood pressure cuff to the end of (manual) deflation of the upper arm blood pressure cuff (approximately 30-60 seconds)</time_frame>
    <description>Simultaneous auscultatory blood pressure measurements by 2 trained observers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic Pressure</measure>
    <time_frame>From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds)</time_frame>
    <description>Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic Pressure</measure>
    <time_frame>From the start of manual inflation of the upper arm blood pressure cuff to the end of (manual) deflation of the upper arm blood pressure cuff (approximately 30-60 seconds)</time_frame>
    <description>Simultaneous auscultatory blood pressure measurements by 2 trained observers</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Outpatients Complicated Hypertension Clinic</arm_group_label>
    <description>This study population consists of approximately 200 adult male and female patient participants (≥ 19 years of age; minimum 30% male/female) who are referred to the Complicated Hypertension Clinic at the Saint John Regional Hospital (SJRH) and who are willing to volunteer to consent to participate in the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsewave Health Monitor (PAD-2A) Device</intervention_name>
    <description>This is an observational, comparison study of blood pressure measurements. The objective of this study is to calibrate the blood pressure measurements of the Pulsewave Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer auscultatory blood pressure measurements via an aneroid sphygmomanometer (reference device), as per the ISO 81060-2: AMD_2020 universal protocol.</description>
    <arm_group_label>Outpatients Complicated Hypertension Clinic</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        For this study, we will recruit and consent approximately 200 adult male and female patient&#xD;
        participants (≥ 19 years of age; minimum 30% male/female) who are referred to the&#xD;
        Complicated Hypertension Clinic at the Saint John Regional Hospital (SJRH) and who are&#xD;
        willing to volunteer to consent to participate in the study. Eligibility of participants&#xD;
        for this study is based on the inclusion and exclusion criteria as per the ISO 81060-2:&#xD;
        AMD_2020 protocol, as described below.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults ≥ 19 years of age (minimum 30% male/female)&#xD;
&#xD;
          -  Wrist circumference between 13.5 cm. - 23 cm. (5.3 in. - 9.1 in.):&#xD;
&#xD;
               -  At least 20% of total participants, greater than 20.6 cm.&#xD;
&#xD;
               -  At least 20% of total participants, between 18.3 cm. &amp; 20.6 cm.&#xD;
&#xD;
               -  At least 20% of total participants, between 15.9 cm. &amp; 18.3 cm.&#xD;
&#xD;
               -  At least 20% of total participants, less than 15.9 cm.&#xD;
&#xD;
               -  At least 10% of total participants, greater than 21.8 cm.&#xD;
&#xD;
               -  At least 10% of total participants, less than 14.7 cm.&#xD;
&#xD;
          -  Willing to volunteer to participate and to sign the study specific informed consent&#xD;
             form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Wrist circumference less than 13.5 cm. (5.3 in.) or greater than 23 cm. (9.1 in)&#xD;
&#xD;
          -  Hand or body tremors&#xD;
&#xD;
          -  Irregular heart rhythm (bigeminy, trigeminy, isolated ventricular premature beat&#xD;
             (VPB), atrial fibrillation)&#xD;
&#xD;
          -  Korotkoff sound K5 not audible&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  A musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated&#xD;
             on the arm&#xD;
&#xD;
          -  Unwilling to volunteer to participate and to sign the study specific informed consent&#xD;
             form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin MacKinnon, MD, FRCP(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complicated Hypertension Clinic, Saint John Regional Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sohrab Lutchmedial, MD, FRCP(C)</last_name>
    <phone>506-648-6101</phone>
    <email>sohrab.lutchmedial@horizonnb.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Keith R. Brunt, PhD</last_name>
    <phone>506-636-6974</phone>
    <email>keith.brunt@dal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Horizon Health Network</name>
      <address>
        <city>Saint John</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>https://clouddx.com/</url>
    <description>Cloud DX device company website.</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiovascular Research New Brunswick</investigator_affiliation>
    <investigator_full_name>Sohrab Lutchmedial, MD, FRCPC</investigator_full_name>
    <investigator_title>Co-Director of CVR-NB/ Director of the New Brunswick Heart Centre (NBHC) Cardiac Catheterization Laboratory</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Vital sign monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Currently, the clinical research group is undecided regarding individual participant data (IDP) sharing with other researchers upon completion of this study, although it is acknowledged that the practice of data sharing among scientists, clinicians, and other professionals is of increasing importance, particularly for transparency in clinical research studies.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

